People · Operator
Named in public records as an officer, director or promoter · active 2008–2024 · Biotech / Pharma, Other, Manufacturing, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Araceli Biosciences Inc. | — | Biotech / Pharma | Series A | $14.5M | $50.4M | 2024 |
| Rally Marketing Group INC | — | Other | Seed | $4.8M | $27.9M | 2008 |
| Columbia Nutritional, LLC | — | Manufacturing | Seed | $4.2M | $10.9M | 2018 |
| Vantos Inc | — | Other Technology | Pre-Seed | $1.4M | $18.4M | 2009 |
Kevin Gabelein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Gabelein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Rhine | 2 | 5 |
| David Johnson | 1 | 35 |
| Andrew Smith | 1 | 14 |
| Sean O'Neill | 1 | 5 |
| Howard Tullman | 1 | 5 |
| J. William Freytag | 1 | 4 |
| PETER VAN OPPEN | 1 | 4 |
| BRIAN TURNER | 1 | 3 |
| Andy Dale | 1 | 3 |
| Kirk Malloy | 1 | 2 |
| LISA CLARKE | 1 | 2 |
| Brian C. Turner | 1 | 2 |
| Matt Beaudet | 1 | 2 |
| Binh Do | 1 | 2 |
| Dean C. Allen | 1 | 2 |
| Christopher Slatt | 1 | 2 |
| Kevin C. Gabelein | 1 | 2 |
| Shawn William MacDonald | 1 | 1 |
| Kirk William Malloy | 1 | 1 |
| William Cortelyou | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.